PenderFund Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

PenderFund Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-96,600	Closed	-$352K	–	164
2025 Q1	$352K	Buy	+96,600	New	+$322K	0.1%	69

PenderFund Capital Management's CKPT Position: Q2 2025 in Review

PenderFund Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 96,600 shares — an estimated $352K sold.

PenderFund Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $352K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

PenderFund Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
PenderFund Capital Management sold 96,600 Checkpoint Therapeutics shares in Q2 2025, an estimated $352K.
PenderFund Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
PenderFund Capital Management's Checkpoint Therapeutics position peaked at $352K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on PenderFund Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.